VR-ACT After Stroke: a Feasibility Study

NCT ID: NCT06990646

Last Updated: 2025-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-11-30

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This exploratory project aims to develop and pilot test, in a parallel group randomized controlled trial (RCT) design, the feasibility, acceptability, and preliminary efficacy of a self-management virtual reality (VR) 8-week program for pain management and mental health in patients with chronic post-stroke pain (CPSP), in two assessment moments (pre- to post-intervention).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project has three objectives: O1) to develop and test the feasibility and acceptability of a 8-week VR ACT program (VR-ACT) in a sample of CPSP patients; O2) to pilot test the efficacy of VR-ACT in improving pain, mental health, and adaptive psychological processes and skills, and in reducing the functional connectivity of the Triple Network (DMN, SN, and FPN); O3) To examine the cost-effectiveness of the VR-ACT. The current project will conduct a parallel group design Randomized Controlled Trial (RCT) and will follow a multi-method approach (qualitative and quantitative assessment).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Pain Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

VR-ACT

8 modules of 3D immersive skills training (2 targeting awareness regulation skills; 3 promoting acceptance; 3 focused on behavioral change and commitment to valued action)

Group Type EXPERIMENTAL

VR-ACT

Intervention Type BEHAVIORAL

8 MODULES OF 3D VIRTUAL REALITY Modules 1 \& 2: Awareness Regulation Skills Modules 3, 4 \& 5: Acceptance of Pain and Internal Experiences Modules 6, 7 \& 8: Behavior Change and Valued Action

Sham-VR

8 2D non-immersive distracting video animations delivered through a VR headset

Group Type SHAM_COMPARATOR

Sham-VR

Intervention Type BEHAVIORAL

8 2D non-immersive distracting video-animations delivered through a VR headset.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VR-ACT

8 MODULES OF 3D VIRTUAL REALITY Modules 1 \& 2: Awareness Regulation Skills Modules 3, 4 \& 5: Acceptance of Pain and Internal Experiences Modules 6, 7 \& 8: Behavior Change and Valued Action

Intervention Type BEHAVIORAL

Sham-VR

8 2D non-immersive distracting video-animations delivered through a VR headset.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* medical diagnosis of CPSP;
* age between 18 and 80;
* implicit de facto internet and computer literacy;
* willingness to comply with the study procedures.

Exclusion Criteria

* currently with active malignancy; -
* severe cognitive impairment;
* currently undergoing any psychological intervention or VR-delivered pain management program;
* current severe psychiatric symptoms (i.e., psychosis; severe depression; non-suicidal self-injury; suicide attempt in the last month);
* language impairment with severe comprehension deficit;
* history of photosensitive epilepsy or previous experience of severe simulator sickness;
* other neurological conditions (e.g., dementia; Parkinson´s).
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Unidade Local de Saúde de Coimbra, EPE

OTHER

Sponsor Role collaborator

University of Coimbra

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sérgio Andrade Carvalho

Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Sérgio A Carvalho, PhD

Role: CONTACT

+351 239 851 450

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023.13402.PEX

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

2023.13402.PEX

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post-stroke Pain tAN-fMRI
NCT07144436 NOT_YET_RECRUITING NA
TMS and Exercise for Post-stroke Pain
NCT04672044 COMPLETED PHASE1